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Results: In 3 out of the first 4 cases, ITPD detected EPID dose 
differences due to anatomical changes. The figure shows an 
example case (A) of ITPD detecting the anatomical change. 





Conclusions: Our simulations show that when ITPD is 
implemented clinically, it can automatically detect 'gross' 
anatomical changes occurring during the course of (chemo-) 
radiotherapy in lung cancer patients, which can be used as a 
trigger for adaptive radiotherapy. Only patients were 
analyzed who underwent treatment adaptation based on 
visually detected anatomic differences.  
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Purpose/Objective: To establish the optimal planning risk 
volume (PRV) to the lenses for nasal cavity and paranasal 
sinus cancer patients during image guided intensity 
modulated radiation therapy (IG-IMRT). 
Materials and Methods: Geometrical uncertainties of the 
lenses were evaluated for retrospective group (RG) of 
patients for whom PRV for lenses was not applied. 
Differences between planned and delivered maximum doses 
to the lenses were established for every fraction dose and for 
cumulative dose. Maximum doses were evaluated as a dose 
received by 0.02 cm3 of the lenses. Finally, relations between 
dose differences and geometrical uncertainties were analysed 
to establish an optimal PRV for the lenses. The PRV was 
calculated according to the formula: 1.3 × Σ + 0.5 × σ 
(McKenzie A, et al. Radiother Oncol 2002). Obtained results 
were evaluated in the prospective group (PG) of patients for 
whom calculated PRV was applied. 
Results: Retrospective study (RG) based on the 330 
observations from 10 nasal cavity and paranasal sinus cancer 
patients. The average shifts of the lenses have not got any 
dominant directionality, and were lower than 1 mm for each 
direction. Nevertheless, intra-patient analysis shows large 
variation of the lenses position during IG-IMRT. The 
systematic and random errors equaled respectively: 0.6 mm 
and 2.3 mm in R-L direction; 0.8 mm and 1.6 mm in C-C 
direction; and 0.4 mm and 1.5 mm in A-P direction.  
The differences between planned and delivered doses have 
normal distribution (p=0.542, Shapiro-Wilk's test). High 
mobility of the lenses leads to the fact that only for 11.1% 
observations, the differences between planned and delivered 
doses are lower than 3%. The delivered doses were: higher 
than planned by 10% for 40.7% of observations; higher than 
30% for 16.7 % of observations; and higher than 50% for 5.6% 
of observations. The calculated margins were respectively: 
1.9 mm in R-L direction; 1.8 mm in C-C direction, and 1.3 
mm in A-P direction. As a result, clinical PRV for lenses was 
established on 2 mm. To evaluate applied margin, an analysis 
of dose distributions for 10 prospectively treated patients 
(PG) was done. The dose distribution in planning target 
volume for the RG (without PRV) and for the PG (2 mm PRV 
for lenses) was comparable (p=0.122, Mann-Whitney test). 
The differences between planned and delivered doses in 
lenses were significantly smaller for PG (p=0.013, 
Kolmogorov-Smirnov test). For PG the delivered doses were: 
higher than planned by 10% for 17.4% of observations; higher 
than 30% for 3.3 % of observations; and higher than 50% for 
0.8% of observations. 
Conclusions: Our study showed that for radiation therapy of 
nasal cavity and paranasal sinus cancer, the planning risk 
volume for the lenses could be defined as 2 mm. This margin 
does not affect on the dose distribution in planning target 
volume and effectively reduce the differences between 
planned doses and delivered doses in lenses.  
